A carregar...
CGRP Monoclonal Antibody use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.
BACKGROUND: Monoclonal antibodies (mAbs) to calcitonin gene-related peptide (CGRP) or its receptor have clinical trial evidence in adults with headache, but data are lacking in adolescents. OBJECTIVE: To describe the safety and efficacy of CGRP monoclonal antibody (mAb) treatment in adolescents with...
Na minha lista:
| Publicado no: | Pediatr Neurol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770043/ https://ncbi.nlm.nih.gov/pubmed/33232919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pediatrneurol.2020.09.014 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|